The evidence increasingly points to a laboratory origin for COVID-19, not a natural spillover from the Wuhan wet market. In this episode, returning guest Steven Quay, MD, PhD, FCAP, Chairman, President, & CEO of Atossa Therapeutics, walks through the case built in his book, The Code as Witness. He explains why none of the animals or market workers tested showed signs of infection, how a 2012 mining accident produced a coronavirus strain closely related to SARS-CoV-2, and what the furin cleavage site reveals about possible genetic engineering. The conversation also covers gain-of-function research, biosafety failures at the Wuhan Institute of Virology, and concrete steps that could help prevent the next pandemic.
About the Guest:Steven Quay, MD, PhD, FCAP
Chairman, President, & CEO of Atossa Therapeutics
WebsiteLinkedInX:
@quay_drOrder your copy of Dr. Steven Quay's book,
The Code as Witness,
here.
Contact Dr. Mitchell:Email: care@mitchellmedicalgroup.com
WebsiteInstagramYouTubeFacebookLinkedInOrder your copy of Dr. Mitchell’s latest book,
Conquering Candida,
here.Be sure to visit
ImmunoLytics & use coupon code
SmartestDoc for 5% off
